Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Nov;34(11):1622–1626. doi: 10.1136/gut.34.11.1622

Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?

C J McKay 1, C W Imrie 1, J N Baxter 1
PMCID: PMC1374434  PMID: 7902312

Abstract

Somatostatin was first suggested for the treatment of acute pancreatitis more than 15 years ago but despite many studies, its role in the management of this condition remains unclear. The experimental and clinical studies are reviewed and the physiological actions of somatostatin, which may influence the course of acute pancreatitis are examined. It is concluded that although some reports suggest a trend towards improved survival and lessened complication rate with somatostatin treatment, insufficient evidence of benefit exists to support the use of somatostatin or its analogue in the treatment or prophylaxis against acute pancreatitis in routine clinical practice.

Full text

PDF
1622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adham N. F., Song M. K., Haberfelde G. C. Relationship between the functional status of the reticuloendothelial system and the outcome of experimentally induced pancreatitis in young mice. Gastroenterology. 1983 Mar;84(3):461–469. [PubMed] [Google Scholar]
  2. Adler G., Koch A., Kern H. F. Effect of somatostatin on rat exocrine pancreatic secretory process in normal and diseased state. Z Gastroenterol. 1980 Aug;18(8):418–426. [PubMed] [Google Scholar]
  3. Augelli N. V., Hussain S. M., McKain M. M., Fietsam R., Bierema T., Fegley M., Bendick P., Villalba M., Lucas R., Glover J. L. Effect of SMS201-995 (a long-acting somatostatin analog) on bile-induced acute hemorrhagic pancreatitis in the dog. Am Surg. 1989 Jun;55(6):389–391. [PubMed] [Google Scholar]
  4. Banks R. E., Evans S. W., Alexander D., Van Leuven F., Whicher J. T., McMahon M. J. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut. 1991 Apr;32(4):430–434. doi: 10.1136/gut.32.4.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baxter J. N., Jenkins S. A., Day D. W., Roberts N. B., Cowell D. C., Mackie C. R., Shields R. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg. 1985 May;72(5):382–385. doi: 10.1002/bjs.1800720516. [DOI] [PubMed] [Google Scholar]
  6. Baxter J. N., Jenkins S. A., Day D. W., Shields R. Effects of a somatostatin analogue (SMS 201-995) on hepatic and splenic reticulo-endothelial function in the rat. Br J Surg. 1985 Dec;72(12):1005–1008. doi: 10.1002/bjs.1800721224. [DOI] [PubMed] [Google Scholar]
  7. Becker R. H., Scholtholt J., Schölkens B. A., Jung W., Speth O. A microsphere study on the effects of somatostatin and secretin on regional blood flow in anesthetized dogs. Regul Pept. 1982 Nov;4(6):341–351. doi: 10.1016/0167-0115(82)90145-8. [DOI] [PubMed] [Google Scholar]
  8. Binmoeller K. F., Harris A. G., Dumas R., Grimaldi C., Delmont J. P. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut. 1992 Aug;33(8):1129–1133. doi: 10.1136/gut.33.8.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Boden G., Sivitz M. C., Owen O. E., Essa-Koumar N., Landor J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science. 1975 Oct 10;190(4210):163–165. doi: 10.1126/science.1166308. [DOI] [PubMed] [Google Scholar]
  10. Bordas J. M., Toledo V., Mondelo F., Rodés J. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res. 1988;29(2-3):106–108. doi: 10.1159/000180981. [DOI] [PubMed] [Google Scholar]
  11. Bottani G., Lucev M., Franco F., Rovati L. L'uso della somatostatina nella terapia della pancreatite acuta. Studio clinico controllato. Minerva Chir. 1985 Oct 15;40(19):1337–1340. [PubMed] [Google Scholar]
  12. Broe P. J., Zinner M. J., Cameron J. L. A clinical trial of cimetidine in acute pancreatitis. Surg Gynecol Obstet. 1982 Jan;154(1):13–16. [PubMed] [Google Scholar]
  13. Browder I. W., Sherwood E., Williams D., Jones E., McNamee R., DiLuzio N. Protective effect of glucan-enhanced macrophage function in experimental pancreatitis. Am J Surg. 1987 Jan;153(1):25–33. doi: 10.1016/0002-9610(87)90197-8. [DOI] [PubMed] [Google Scholar]
  14. Börsch G., Bergbauer M., Nebel W., Sabin G. Der Einfluss von Somatostatin auf die Amylasespiegel und Pankreatitisrate nach ERCP. Med Welt. 1984 Jan 27;35(4):109–112. [PubMed] [Google Scholar]
  15. Choi T. K., Mok F., Zhan W. H., Fan S. T., Lai E. C., Wong J. Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut. 1989 Feb;30(2):223–227. doi: 10.1136/gut.30.2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cimarelli S., Anglesio V., Giovanelli A., Bavuso D. L'uso della somatostatina nelle pancreatiti acute di origine biliare. Minerva Med. 1987 Apr 15;78(7):483–487. [PubMed] [Google Scholar]
  17. Creutzfeldt W., Lembcke B., Fölsch U. R., Schleser S., Koop I. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med. 1987 May 29;82(5B):49–54. doi: 10.1016/0002-9343(87)90426-8. [DOI] [PubMed] [Google Scholar]
  18. D'Amico D., Favia G., Biasiato R., Casaccia M., Falcone F., Fersini M., Marrano D., Napolitano F., Oliviero S., Rodolico A. The use of somatostatin in acute pancreatitis--results of a multicenter trial. Hepatogastroenterology. 1990 Feb;37(1):92–98. [PubMed] [Google Scholar]
  19. Davliakos G. P., Petraiuolo W. J., Sell H. W., Jr, Smith W., Marrangoni A. G. Treatment of experimentally induced pancreatitis in ex vivo perfused canine pancreas with the somatostatin analogue octreotide. Curr Surg. 1990 Sep-Oct;47(5):343–345. [PubMed] [Google Scholar]
  20. De Rai P., Franciosi C., Confalonieri G. M., Biffi R., Andreoni B., Uggeri F., Malesci A. Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop. Int J Pancreatol. 1988 Jul;3(5):367–373. doi: 10.1007/BF02788470. [DOI] [PubMed] [Google Scholar]
  21. Dollinger H. C., Raptis S., Pfeiffer E. F. Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res. 1976 Jan;8(1):74–78. doi: 10.1055/s-0028-1093677. [DOI] [PubMed] [Google Scholar]
  22. Donahue P. E., Akimoto H., Ferguson J. L., Nyhus L. M. Vasoactive drugs in acute pancreatitis. Arch Surg. 1984 Apr;119(4):477–480. doi: 10.1001/archsurg.1984.01390160103020. [DOI] [PubMed] [Google Scholar]
  23. Dürr H. K., Maroske D., Zelder O., Bode J. C. Glucagon therapy in acute pancreatitis. Report of a double-blind trial. Gut. 1978 Mar;19(3):175–179. doi: 10.1136/gut.19.3.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gaginella T. S., O'Dorisio T. M., Fassler J. E., Mekhjian H. S. Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin. Metabolism. 1990 Sep;39(9 Suppl 2):172–175. doi: 10.1016/0026-0495(90)90239-9. [DOI] [PubMed] [Google Scholar]
  25. Gjørup I., Roikjaer O., Andersen B., Burcharth F., Hovendal C., Pedersen S. A., Christiansen P., Wara P., Andersen J. C., Balslev I. A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. Surg Gynecol Obstet. 1992 Nov;175(5):397–400. [PubMed] [Google Scholar]
  26. Guelrud M., Mendoza S., Viera L., Gelrud D. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc. 1991 Jan-Feb;37(1):44–47. doi: 10.1016/s0016-5107(91)70619-6. [DOI] [PubMed] [Google Scholar]
  27. Gullo L., Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet. 1991 Aug 31;338(8766):540–541. doi: 10.1016/0140-6736(91)91102-z. [DOI] [PubMed] [Google Scholar]
  28. Gullo L., Priori P., Scarpignato C., Baldoni F., Mattioli G., Barbara L. Effect of somatostatin 14 on pure human pancreatic secretion. Dig Dis Sci. 1987 Oct;32(10):1065–1070. doi: 10.1007/BF01300189. [DOI] [PubMed] [Google Scholar]
  29. Jenkins S. A., Baxter J. N., Day D. W., Al-Sumidaie A. M., Leinster S. J., Shields R. The effects of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxaemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin Wochenschr. 1986;64 (Suppl 7):100–106. [PubMed] [Google Scholar]
  30. Klar E., Rattner D. W., Compton C., Stanford G., Chernow B., Warshaw A. L. Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg. 1991 Aug;214(2):168–174. doi: 10.1097/00000658-199108000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krulich L., Dhariwal A. P., McCann S. M. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968 Oct;83(4):783–790. doi: 10.1210/endo-83-4-783. [DOI] [PubMed] [Google Scholar]
  32. LaFerla G., Gordon S., Archibald M., Murray W. R. Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas. 1986;1(2):160–163. doi: 10.1097/00006676-198603000-00009. [DOI] [PubMed] [Google Scholar]
  33. Ladefoged K., Christensen K. C., Hegnhøj J., Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut. 1989 Jul;30(7):943–949. doi: 10.1136/gut.30.7.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lankisch P. G., Koop H., Winckler K., Fölsch U. R., Creutzfeldt W. Somatostatin therapy of acute experimental pancreatitis. Gut. 1977 Sep;18(9):713–716. doi: 10.1136/gut.18.9.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Levant J. A., Secrist D. M., Resin H., Sturdevant R. A., Guth P. H. Nasogastric suction in the treatment of alcoholic pancreatitis. A controlled study. JAMA. 1974 Jul 1;229(1):51–52. [PubMed] [Google Scholar]
  36. Meshkinpour H., Molinari M. D., Gardner L., Berk J. E., Hoehler F. K. Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study. Gastroenterology. 1979 Oct;77(4 Pt 1):687–690. [PubMed] [Google Scholar]
  37. Naeije R., Salingret E., Clumeck N., De Troyer A., Devis G. Is nasogastric suction necessary in acute pancreatitis? Br Med J. 1978 Sep 2;2(6138):659–660. doi: 10.1136/bmj.2.6138.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Niederau C., Niederau M., Lüthen R., Strohmeyer G., Ferrell L. D., Grendell J. H. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology. 1990 Oct;99(4):1120–1127. doi: 10.1016/0016-5085(90)90633-c. [DOI] [PubMed] [Google Scholar]
  39. Nubiola P., Badia J. M., Martinez-Rodenas F., Gil M. J., Segura M., Sancho J., Sitges-Serra A. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg. 1989 Jul;210(1):56–58. doi: 10.1097/00000658-198907000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Prinz R. A., Pickleman J., Hoffman J. P. Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg. 1988 Jan;155(1):36–42. doi: 10.1016/s0002-9610(88)80255-1. [DOI] [PubMed] [Google Scholar]
  41. Reichlin S. Somatostatin. N Engl J Med. 1983 Dec 15;309(24):1495–1501. doi: 10.1056/NEJM198312153092406. [DOI] [PubMed] [Google Scholar]
  42. Russello D., Puleo S., Li Destri G., Scuderi M., Latteri F. Ruolo della somatostatina e della nutrizione parenterale nel trattamento della pancreatite acuta. Esperienze personali. Minerva Chir. 1989 Mar 15;44(5):843–847. [PubMed] [Google Scholar]
  43. Schlarman D. E., Beinfeld M. C., Andrus C., Kaminski D. L. Effects of somatostatin on acute canine experimental pancreatitis. Int J Pancreatol. 1987 Aug;2(4):247–255. doi: 10.1007/BF02788402. [DOI] [PubMed] [Google Scholar]
  44. Schröder T., Millard R. W., Nakajima Y., Gabel M., Joffe S. N. Microcirculatory effects of somatostatin in acute pancreatitis. Eur Surg Res. 1988;20(1):82–88. doi: 10.1159/000128745. [DOI] [PubMed] [Google Scholar]
  45. Schwedes U., Althoff P. H., Klempa I., Leuschner U., Mothes L., Raptis S., Wdowinski J., Usadel K. H. Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res. 1979 Dec;11(12):655–661. doi: 10.1055/s-0028-1092793. [DOI] [PubMed] [Google Scholar]
  46. Skude G., Wehlin L., Maruyama T., Ariyama J. Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography. Gut. 1976 Feb;17(2):127–132. doi: 10.1136/gut.17.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Szabo S. Somatostatin stimulates clearance and hepatic uptake of colloidal carbon in the rat. Life Sci. 1983 Nov 14;33(20):1975–1980. doi: 10.1016/0024-3205(83)90735-x. [DOI] [PubMed] [Google Scholar]
  48. Szabo S., Usadel K. H. Cytoprotection - organoprotection by somatostatin: gastric and hepatic lesions. Experientia. 1982 Feb 15;38(2):254–256. doi: 10.1007/BF01945097. [DOI] [PubMed] [Google Scholar]
  49. Tulassay Z., Papp J. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest Endosc. 1991 Jan-Feb;37(1):48–50. doi: 10.1016/s0016-5107(91)70620-2. [DOI] [PubMed] [Google Scholar]
  50. Usadel K. H., Kessler H., Rohr G., Kusterer K., Palitzsch K. D., Schwedes U. Cytoprotective properties of somatostatins. Klin Wochenschr. 1986;64 (Suppl 7):59–63. [PubMed] [Google Scholar]
  51. Usadel K. H., Leuschner U., Uberla K. K. Treatment of acute pancreatitis with somatostatin: a multicenter double blind study. N Engl J Med. 1980 Oct 23;303(17):999–1000. doi: 10.1056/NEJM198010233031710. [DOI] [PubMed] [Google Scholar]
  52. Vinik A., Moattari A. R. Use of somatostatin analog in management of carcinoid syndrome. Dig Dis Sci. 1989 Mar;34(3 Suppl):14S–27S. doi: 10.1007/BF01536042. [DOI] [PubMed] [Google Scholar]
  53. Young M. J., Bresnitz E. A., Strom B. L. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med. 1983 Aug;99(2):248–251. doi: 10.7326/0003-4819-99-2-248. [DOI] [PubMed] [Google Scholar]
  54. Zhu Z. H., Holt S., el-Lbishi M. S., Grady T., Taylor T. V., Powers R. E. A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas. 1991 Sep;6(5):609–613. doi: 10.1097/00006676-199109000-00016. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES